18506161

Source:http://linkedlifedata.com/resource/pubmed/id/18506161

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010583, umls-concept:C0014653, umls-concept:C0030705, umls-concept:C0035647, umls-concept:C0043092, umls-concept:C0560187, umls-concept:C0596244
pubmed:issue	7
pubmed:dateCreated	2008-6-30
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18506161-17937462
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101261802
pubmed:status	PubMed-not-MEDLINE
pubmed:month	Jul
pubmed:issn	1745-8390
pubmed:author	pubmed-author:LangfordCarol ACA, pubmed-author:MolloyEamonn SES
pubmed:issnType	Electronic
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	340-1
pubmed:year	2008
pubmed:articleTitle	Balancing efficacy and cancer risk of cyclophosphamide for patients with Wegener's granulomatosis.
pubmed:affiliation	Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, OH 44195, USA.
pubmed:publicationType	Journal Article, Comment